Deferoxamine (Desferal, DFO)

Indications


Pharmacology

  • Iron Chelation
    • Short half-life: requires continuous IV or SQ infusion

Administration

  • IV: administered over 10-12 hrs
  • SQ

Adverse Effects

  • xxx

References

  • xxx